干扰素联合阿德福韦酯治疗乙型肝炎和丙型肝炎重叠感染疗效观察

目的 探讨干扰素联合阿德福韦酯治疗乙型肝炎和丙型肝炎重叠感染的临床疗效.方法 回顾性分析乙型肝炎和丙型肝炎重叠感染患者90例,根据治疗方法不同分为两组,对照组43例给予干扰素治疗,治疗组47例给予干扰素联合阿德福韦酯治疗,比较两组的临床疗效.结果 治疗48周后对照组HBV DNA及HCV RNA阴转率分别为32.6%、41.9%,治疗组分别为80.9%、72.3%,治疗组明显优于对照组,差异均有统计学意义（χ^2=6.43、5.28,均P＜0.05）.结论 干扰素联合阿德福韦酯治疗乙型肝炎和丙型肝炎重叠感染患者具有良好效果,值得临床推广.

Effects of IFN combined with adefovir dipivoxil in the treatment of patients with hepatitis B and hepatitis C overlapping infection

Objective To explore the clinical effect of IFN combined with adefovir dipivoxil in the treatment of patients with the hepatitis B and hepatitis C overlapping infection.Methods 90 cases of hepatitis B overlapping infection of hepatitis C were divided into control group（n =43） and treatment group（n =47）.The control group was treated with IFN,the treatment group was treated with IFN and adefovir dipivoxil.Results The treatment group was better than the control group in the liver function,HBV DNA,HCV RNA.At the 24th weeks,the negative rates of HBV DNA and HCV RNA in the control group were 14 （32.6%） and 18 （41.9%）,while there were were 38 （80.9%） and 34（72.3%） in the treatment group.There was significant differences between the two groups（χ^2 =6.43,5.28,all P 〈 0.05）.Conclusion The clinical efficacy of IFN combined with adefovir dipivoxil for the hepatitis B and hepatitis C overlapping infection patients was significant better than IFN,which is worthy of clinical application.